Loading...

SRPT SAREPTA THERAPEUTICS INC Earnings Reports 8-K Filing

SRPT

SRPT

SAREPTA THERAPEUTICS INC

(SRPT)

2026 8-K

Financial Results Update

CEO Retirement Announcement

Financial Results Released

Business Update

Debt Exchange Agreement

Convertible Notes Exchange

CEO Equity Grant

Financial Results Announced

Convertible Notes Exchange

Debt Exchange Agreement

Management Change

Clinical Trials

Reduction in Force

Rights Offerings

Earnings Announcement

Credit Agreement

Financial Results

Collaboration Agreement

Amendment to Incentive Plan

Financial Results

FDA Approval of ELEVIDYS

Annual Meeting Results

External Links:

On May 6, 2026, Sarepta Therapeutics, Inc. announced its financial results for Q1 2026 in a press release, detailing its operational performance and financial condition. This event does not indicate significant changes from an investor perspective.

AI Assistant

SAREPTA THERAPEUTICS INC

2026

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.